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concentration in immunodepressed male laboratory mice (Mus musculus) . PHYSIOL BEHAV 61(6) 907–917, 1997.—Recent
ideas suggest that current immunocompetence may act as a constraint on behavioural and physiological decisions, where these
risk imposing an additional burden on immune function. We tested this in the context of time budgeting and the secretion of the
potentially immunodepressive hormones testosterone and corticosterone, by treating adult male CFLP laboratory mice with anti-
thymocyte serum (ATS) to depress thymus-mediated immune function. In comparison with males given a naive rabbit serum
(NRS) vehicle control, ATS-treated mice showed a reduction in serum testosterone concentration, aggressive behaviour, and
general activity, and maintained time spent sleeping, relative to pretreatment levels. Behaviours that differed between treatments
correlated with measures of immunodepression (reduction in relative thymus weight or serum total IgG concentration), but
relationships with behavioural changes were independent of those with testosterone. There was little evidence that changes were
affected by social status. The results are discussed in the context of the adaptive modulation of immune function and physiological
and behavioural decision-making. q 1997 Elsevier Science Inc.
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RECENT discussions have suggested that immune function has
an important influence on physiological and behavioural deci-
sion-making [e.g., (6,14,26,32,35)] . In particular, several hor-
mones and cytokines from the gonads and adrenal, thyroid, thy-
mus, pituitary, and pineal glands interact directly or indirectly
with the immune system [e.g., (1,14,30,31)] , with the effect that
some components of the immune response may become down-
regulated. Relationships between immunodepression and the se-
cretion of androgens and glucocorticoids have been appreciated
for some time [(1,13,15,16,28) but see e.g., (7,31) for evidence
of other immunomodulatory effects] , and there is evidence that
feedback mechanisms operate to modulate the secretion of hor-
mones as immune status varies (15). More recently, such mech-
anisms have been viewed as an element in the adaptive modu-
lation of hormone secretion, behaviour, and morphological
(particularly secondary sexual) characters, where these have con-
sequences for immunocompetence [(5,14,32,35), but see (27)] .
In this view, immunocompetence may be conserved (by down-
regulating hormone secretion) and, thus, act as a constraint on
other categories of decision-making (e.g., sexual display) , or im-
munodepression may be tolerated and reflect an adaptive life his-
tory decision to shift metabolic resources between physiological
systems, with immunodepressive hormones providing part of the
mechanism for regulating investment in immune function
(5,32,35).
In a series of experiments with male laboratory mice of the
CFLP strain, we have shown that aggressive behaviour and se-
rum hormone (testosterone and corticosterone) and total IgG [a
bystander measure of immunocompetence (4–6)] concentra-
tions covary in ways that are consistent with the adaptive mod-
ulation hypothesis and influence resistance to an experimental
infection of the piroplasmid protozoan Babesia microti (3–
6,32). Moreover, interrelationships differ between males of dif-
ferent social status and between social /sexual contexts in accor-
dance with rank-related modulation of hormone secretion and an
adaptive trade-off between immunocompetence and apparent re-
productive opportunity (2,5,32) .
So far, we have examined these interrelationships only as they
occur spontaneously within individuals. If hormone concentra-
tions and behaviour are modulated in response to current immune
status, however, we should be able to manipulate immunocom-
petence experimentally and predict resultant hormonal and be-
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havioural changes. A consistent finding in our previous work has
been that, although increased aggressive behaviour and testos-
terone concentration were both associated with reduced immu-
nocompetence and resistance to B. microti , they were not them-
selves significantly correlated (5,6,32) . This suggests that
hormonal and behavioural changes may provide independent av-
enues of response to variation in immune status, rather than be-
haviour reflecting changes in underlying hormonal causal mech-
anisms [e.g., (36)] .
To test our hypothesis, an immunodepressive procedure was
required that would induce significant temporary immunode-
pression while causing minimal undesirable side effects. For this
reason, cytotoxic drugs (e.g., corticosteroids) , whole-body irra-
diation, and ablation of primary lymphoid organs by surgery
were inappropriate. Treatment with heterologous antithymocyte
serum (ATS) was selected because the technique is long-estab-
lished, relatively innocuous, and without the general side effects
of other forms of immunodepressive therapy (22,23), and acts
primarily on T-lymphocytes, the helper cells that are essential for
efficient antibody responses and cell-mediated immunity
[(12,23,34) see (22,33) for full reviews]. In addition, there are
known feedback mechanisms mediating the secretion of sex ste-
roids in relation to immunocompetence via the thymus (1,15).
In potentially lowering all circulating T cells in the host, ATS
treatment was preferred to treatment with monoclonal antibodies
that would have required the administration of 2 reagents
(antiCD4 and antiCD8) and suitable controls to achieve the same
end. In this experiment, therefore, we compared changes in be-
haviour and serum testosterone and corticosterone concentrations
in mice treated with rabbit (Oryctolagus cuniculus ) antimouse
thymocyte serum with that of mice treated with serum from naive
rabbits (NRS). It is important to emphasize that the experiment
is restricted to testing the high level associations between behav-
iour and hormonal relationships with immunocompetence pre-
dicted by our previous experiments. It acknowledges, but is
not concerned with, the complex mechanisms and metabolic
pathways that are known to underlie these associations
(14,16,21,30,31). Although feedback from thymus activity is
only one route by which immune function appears to influence
testosterone levels (1,14,15), we predicted a decline in serum
testosterone concentration in ATS-treated animals. Because the
degree of modulation of testosterone has consistently been as-
sociated with immune function and resistance in our previous
experiments [e.g., (5,32)] , this provided an opportunity to test
for the independent effects of reduced immunocompetence on
testosterone concentration and behaviour inferred above. We did
not make any prediction regarding corticosterone concentration
because evidence for modulation of corticosterone relative to im-
mune status in our experiments is weak [(5,32), but see (4)] .
Our prediction with respect to behaviour was that immunode-
pressive treatment would reduce the performance of potentially
stressful activity, such as aggression, and possibly other meta-
bolically demanding behaviours like running and climbing and,
at the same time, increase the incidence of less demanding be-
haviours, such as sleeping. If aggression was reduced, we might
also expect an increase in social investigation, because a reduc-
tion in aggression may destabilize aggressive social relationships
and lead to an increase in information-seeking [e.g., (17,18)] .
In our previous work, high- and low-ranking males differed
in their tendency to modulate testosterone concentration, with the
result that testosterone-related resistance to B. microti was lim-
ited to those of high rank. In the present experiment, therefore,
we tested for an interaction between ATS/NRS treatment and
social rank in the tendency to modulate hormone concentrations
and behaviour.
METHODS
Pre-Experimental Procedure
The subjects were 64 male laboratory mice of the randomly
bred CFLP strain (3) purchased from Bantin and King Ltd, Hull,
UK. At 42 days of age, groups of 4 animals were established in
polypropylene cages (12.5 1 45 1 14 cm) for 3 weeks to accli-
matize to laboratory conditions. From purchase, and throughout
the experiment, animals were maintained on a 12 h:12 h reversed
light:dark cycle (lights on at 2000 h, lights off at 0800 h). Food
(Harlan Tetrad TRM rat/mouse diet) and water were provided
ad lib. At 60 days of age, mice were weighed, given individually
distinctive fur marks using Clairol ‘Nice ‘n’ Easyy, Natural
Black’ hair dye (Bristol Myers Ltd, Uxbridge, UK) and an 88
ml sample of blood was taken from each animal using the tail-
sampling procedure of Smith et al. (32) .
Pretreatment Groups
Three days after the pre-experimental blood samples were
taken, the mice were re-allocated arbitrarily to 16 groups of 4
individuals (cage dimensions as for pre-experimental groups) ,
ensuring that no males within a group had previously encoun-
tered each other. Mice remained in their pretreatment groups for
8 days, during which the amount of time spent in different be-
haviours was recorded in 2 ways, following the methods of Hurst
et al. (19) and the behaviour categories of Mackintosh (24) and
Kareem and Barnard (20). First, all social and nonsocial behav-
iours (Table 1) performed by each individual were recorded us-
ing instantaneous spot-checks. Observations of groups (totalling
21 h) were randomized through the 12h dark phase and carried
out under dim red illumination (3) . Each mouse was observed
as a focal animal for a total of 160 spot-checks over the 8 days,
during which the behaviour being performed at the moment of
observation was recorded on a check sheet. Because social be-
haviours, in particular, tend to be brief, they are likely to be
underrepresented in spot-check samples (19). In addition, there-
fore, groups were observed continuously for 2 5-min periods per
day each (a total of 16 h observation, again randomized through
the dark phase) to record the social behaviours initiated and re-
ceived by each individual, and the identity of the other mice with
which it interacted. In the case of each aggressive interaction, the
degree of escalation involved was recorded on an arbitrary scale
ascending from 1 (threat, usually with no physical contact) to,
rarely, 5 (escalated aggression involving biting and chasing) (see
Table 1) .
Treatment Procedure
At the end of the 8-day pretreatment period, mice were
weighed again and a second 88 ml blood sample taken from the
tail. Pretreatment groups were then allocated randomly to 1 of 2
treatment batches (8 groups each), and mice were separated and
housed singly for 6 days in the same sized cages as pretreatment
groups.
On the day following separation, 8 groups (32 mice) were
injected IP with 0.5 ml ATS (ATS-treated mice) and the re-
maining 8 groups were injected with 0.5 ml of NRS (NRS control
mice) . These injections were repeated on days 2 and 4 of sepa-
ration, except that the volume of serum given was halved on day
2 (0.25 ml) . Two further blood samples were taken. A 20-ml
sample was taken from the tail 1 day after the first ATS/NRS
injection for white blood cell counts. A 50 ml retro-orbital sam-
ple, following Barnard et al. (3) was then taken on day 5 (i.e.,
1 day after the third injection of ATS/NRS). On the final day of
treatment, animals were again weighed and all individuals were
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TABLE 1
BEHAVIOUR CATEGORIES RECORDED DURING THE EXPERIMENT
Social investigation: a composite category combining the olfactory investigatory behaviours Sniff, Nose and Body (sensu 18, 21)
Aggression: a composite category combining Offensive upright, Offensive sideways, Threat, Circling, Bite, and Chase (sensu 18, 21)
Defensive behaviours: a composite category combining Freeze, Flee, Defensive sideways, and Defensive upright (sensu 18, 21)
Allogroom: A mouths and licks the fur of B, mostly on the back and nape
Mount/Attempted mount: A mounts, or attempts to mount, B from the rear
Eat: Consumes food from the food hopper or elsewhere in the cage
Drink: Drinks from the water hopper
Sleep: lying or sitting unalert and eyes observed or presumed (when head of focal mouse obscured in huddle or under food hopper) to be closed
Groom: Grooms genitalia or other body parts, including washing of the face with forepaws
Mobile: Movement around the cage, including running and ambling
Sniff sawdust: sniffs the sawdust on the floor of the cage
Dig sawdust: Digs in the sawdust with forepaws or kicking sawdust with hind legs
Crouch: Crouches on hind quarters
Climb: Climbs up the side of the cage or on the wire lid of the cage with all feet off the ground
Sniff air: Sniffs the air, not directed towards any other animal or part of the cage
Sniff towards observer: Sniffs the air in direction of the observer, normally while climbing against the side of the cage
Upright scan: Stands upright on back legs, usually sniffs the air
Investigate cage: Sniffs the plastic sides of the cage, usually mobile
Jerk: Uncontrolled sudden movement from a standard position, sometimes flipping over completely or followed by fast running
injected with 0.2 ml of a sheep erythrocyte suspension (SRBC)
containing 25 1 107 SRBC/ml (each mouse receiving 5 1 107
SRBC).
Preparation and Preliminary Evaluation of Antithymocyte
Serum
Antimouse thymocyte serum was prepared by a modified pro-
cedure of Levey and Medawar [(23) but see (22) for a full re-
view]. Adult female New Zealand white rabbits were injected
with a thymocyte cell suspension prepared from 11 4-week-old
male C57BL/10 mice (approximately 2–5 1 108 thymus cells /
rabbit) , using aseptic techniques as described for lymphocytes
in Behnke and Parish (8) , differing only in that cell suspensions
were prepared in RPMI medium without foetal calf serum. Rab-
bits were injected intravenously into the lateral ear vein with the
required number of cells in a volume not exceeding 0.9 ml. This
procedure was repeated 2–3 weeks later and the rabbits were
exsanguinated after a further 7 days. The serum was separated
after clotting at 407C, heat inactivated at 567C for 45 min, ali-
quoted, and stored at0807C until required. Note that thymocytes
were obtained from a different mouse strain to the CFLPs used
in the experiment to minimize cross-reactivity with tissue anti-
gens other than those of T-lymphocytes. NRS was obtained from
female New Zealand white rabbits of approximately the same
age.
The efficacy of the ATS preparation in reducing thymocytes
was confirmed through tests carried out prior to its use in the
experiment. Clumping and lysis of target thymocytes were dem-
onstrated in vitro in the presence of complement (1/200 final
dilution of ATS caused 61% reduction in cells in the presence of
1/40 complement and 4.4 1 107 thymocytes from 4-week-old
male CFLP mice) .
In a pre-experimental trial evaluation of the in vivo conse-
quences of injecting our ATS preparation, a group of 3 CFLP
mice were injected IP either with ATS or the same volume of
NRS (0.125, 0.25, and 0.5 ml, respectively) . Peripheral white
blood cell concentrations were measured a day before and after
injection using standard techniques (11). Injection with ATS at
all volumes caused a reduction in the concentration of peripheral
white blood cells averaging 49.2%, whereas injection of NRS to
3 control mice resulted in a mean increase of 18%.
Posttreatment Groups
The day after injection with SRBCs, mice were re-established
in their pretreatment groups, and behavioural observations re-
peated as for pretreatment groups for a further 8 days.
Organ Weights and Blood Assays
At the end of the posttreatment observation period, mice were
weighed for the final time, killed using chloroform, and exsan-
guinated. The kidneys, adrenal glands, spleen, thymus gland, tes-
tes, preputial glands, seminal vesicles, heart, and mesenteric
lymph nodes of each individual were carefully dissected out and
weighed.
Haematology and Haemagglutination Assays
The packed cell volume (PCV) of blood samples was deter-
mined with a standard PCV reader after centrifugation of blood
samples in capillary tubes in a haematocrit centrifuge.
Sheep erythrocytes (SRBC) were obtained fresh in Alsever’s
solution and washed 3 times in phosphate buffered saline (PBS).
The concentration of cells was determined by standard haemo-
cytometry, and the cells were resuspended to the required con-
centration in sterile PBS. For determination of the antibody re-
sponse to SRBC, heat-inactivated (567C for 45 min) mouse sera
were titrated out by serial doubling dilution on plastic microtitre
plates, the first well in each titration containing 40 ml of neat
serum in PBS. A 3% (v/v) washed SRBC suspension in a vol-
ume of 20 ml was added to each well, the plates were left to stand
at 377C for 2 h and the endpoint for haemagglutination was read
by visual inspection.
Measurement of Serum Hormone and IgG Concentrations
Pre-experimental, pretreatment, posttreatment, and terminal
blood samples were assayed for serum concentrations of testos-
terone, corticosterone, and total IgG following Barnard et al.
(4–6).
Testosterone. The concentration of testosterone (ng/ml) was
measured using a Coat-a-County solid-phase 125I total testoster-
one kit (Diagnostic Products Corporation, Los Angeles, CA)
with 25-ml samples of undiluted serum for experimental and cal-
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FIG. 1. Least-squares means from ANOVA of thymus weight (% ter-
minal body weight) in ATS- (Treatment 1) and NRS- (Treatment 2)
treated mice. Bars are least-squares deviations. See text.
ibration assays. Testosterone concentrations were calculated by
reference to the calibration curves.
Corticosterone. The concentration of corticosterone (ng/ml)
was measured using 6-ml samples of undiluted serum and a
Gamma-B 125I-corticosterone kit (Immunodiagnostic Systems
Ltd, Los Angeles, CA) based on double antibody radioimmu-
noassay, as advised by the manufacturers. Corticosterone con-
centrations were calculated by reference to standards provided
with the kit.
Total IgG. Serum total IgG concentration (mg/l) was deter-
mined by the method of Mancini et al. (25) , using radial im-
munodiffusion kits (The Binding Site, Birmingham, UK). Ring
diameters were measured in 2 directions at 907 and the mean was
used to calculate the concentration of immunoglobulins from a
calibration curve obtained using appropriate standards.
In a small number of cases, limited serum volumes meant it
was not possible to obtain a reliable estimate of all 3 serum fac-
tors from a particular sample. As a result, sample sizes in some
subsequent analyses vary [see also (4–6)] .
Statistical Analyses
All analyses were performed using Statgraphics Plusy ver-
sion 7 (Manugistics Ltd, MD). Parametric analyses were used
throughout (data were log10 or square root transformed as nec-
essary and tested for normality using a Kolmogorov-Smirnov 1-
sample test) . Wherever there were a priori reasons for expecting
trends or differences in a particular direction, probabilities as-
sociated with significance tests are indicated as 1-tailed.
RESULTS
Social Rank
Following Barnard et al. (4–6), high- and low-rank catego-
ries within groups were defined on the basis of the ratio of attacks
initiated and received by each male during the pretreatment pe-
riod of grouping. As in our previous experiments, high-ranking
males were identifiable as having high initiation:receipt ratios
and initiating significantly and disproportionately more attacks
over the pretreatment period [ t(26)  3.96, p  0.001]. Two
groups (one from each treatment) , in which the incidence of
aggression was very low, were omitted from later analyses be-
cause it was not possible to allocate males to rank categories. All
other groups comprised 1 high- and 3 low-ranking males. All
analyses relating to social status were based on high- and low-
rank categories and data for those of low rank were averaged
within cages to control for potential problems of nonindepend-
ence (4,5) .
Pre-Experimental Differences in Physiological Measures and
Body Weight
To control for any chance pre-experimental differences in
physiological measures between mice subsequently allocated to
different treatments, we carried out a series of 2-way analyses of
variance (ANOVA) with pre-experimental PCV and serum con-
centrations of testosterone, corticosterone, and total IgG as de-
pendent variables and subsequent treatment and pretreatment
rank category as factors. Pre-experimental body weight was in-
cluded as a covariate. No significant pre-experimental bias
emerged in any variable with respect to treatment or rank cate-
gory. By chance, however, there was a significant difference in
body weight between mice allocated to the 2 treatments, with
mice allocated to ATS treatment being slightly, but significantly,
heavier (mean { SE pregrouping weight  32.01 { 0.27 g) than
those designated as NRS controls (31.03 { 0.33 g) [F(1, 24) 
6.83, p 0.02]. Although there was no association between pre-
experimental body weight and subsequent aggressiveness in pre-
treatment [r(28)  00.07, NS] or posttreatment groups [r(28)
 0.007, NS], body weights relating to pre- and posttreatment
phases were, nevertheless, taken into account when analyzing
treatment effects on aggressive behaviour.
Effects of Treatment on Measures of Immunocompetence
If treatment with ATS depressed immunocompetence, we
should expect an associated reduction in our measures of immune
function.
Two-way ANOVA with treatment and pretreatment rank cat-
egory as factors showed that, as expected, thymus weight (as %
body weight) in ATS-treated animals was reduced relative to
NRS controls [F(1, 25)  3.72, 1-tailed p  0.05, Fig. 1] , im-
plying loss of thymus cells as a result of treatment. There was
no significant difference between rank categories in thymus
weight or any interaction between treatment and rank category.
Depression of immune function was also confirmed by ter-
minal sample haemagglutination responses to SRBCs. Two-way
ANOVA revealed a significant reduction in haemagglutination
titre in ATS-treated males [F(1, 24)  48.33, 1-tailed p 
0.0001, Fig. 2] . There was no main effect or interaction with
respect to rank category and no effect of terminal body weight
(covariate) .
In terms of intercurrent measures, ANOVA of the change in
total IgG concentration across the period of separation and treat-
ment (post- minus pretreatment concentration, controlling for
change in body weight over the same period as a covariate) re-
vealed a sharp decline in ATS-treated mice, compared with an
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FIG. 2. Least-squares means from ANOVA of haemagglutination titre
(1/dilution) in response to SRBC challenge in ATS- and NRS-treated
mice. Treatments and bars as in Fig. 1. See text.
TABLE 2
MEAN { SE SERUM CONCENTRATIONS OF TOTAL IgG, TESTOSTERONE, AND
CORTICOSTERONE FOR ATS-TREATED AND NRS CONTROL MICE AT EACH
SAMPLING POINT DURING THE EXPERIMENT
ATS NRS
Total IgG (mg/l) Pre-exp 1866 { 122 (16) 1841 { 89 (12)
Pretrtmt 2755 { 210 (16) 2708 { 283 (12)
Posttrtmt 2123 { 217 (16) 2994 { 209 (12)
Termination 8748 { 1128 (16) 8930 { 528 (12)
Testosterone (ng/ml) Pre-exp 14.4 { 4.8 (16) 8.7 { 3.2 (12)
Pretrtmt 9.8 { 2.1 (16) 8.2 { 2.6 (12)
Posttrtmt 2.9 { 0.8 (16) 11.1 { 3.7 (12)
Termination 4.37 { 1.4 (16) 3.4 { 1.1 (12)
Corticosterone (ng/ml) Pre-exp 67.0 { 7.0 (16) 82.1 { 12.4 (12)
Pretrtmt 151.2 { 14.2 (15) 115.9 { 15.0 (12)
Posttrtmt 81.2 { 16.9 (16) 88.4 { 21.5 (12)
Termination 187.8 { 24.3 (15) 208.3 { 48.5 (12)
Means based on average values for each rank category per cage (see Methods). Sample
sizes in parentheses.
average increase among NRS-treated animals [F(1, 23) 20.78,
1-tailed p 0.03, Table 2] . There was also a significantly greater
reduction in total IgG among pretreatment high-rankers com-
pared with low-rankers [F(1, 23)  5.05, p  0.04], but no
significant interaction between treatment and rank category.
There was no significant change in body weight over the period
of isolation and treatment. The greater decline among ATS-
treated animals resulted in significantly lower posttreatment IgG
concentrations compared with those treated with NRS [F(1, 23)
 6.93, 1-tailed p  0.01, Table 2] , but there was no difference
or interaction with rank. ATS and NRS animals did not differ
significantly in pretreatment IgG concentrations [F(1, 23) 
0.06, NS, Table 2] .
Total IgG concentration increased significantly over the pe-
riod of grouping in both ATS- and NRS-treated mice before and
after isolation and treatment (Table 2, paired t-test, p  0.005 in
all cases) . Two-way ANOVA of pretreatment change in IgG
revealed no difference in the degree of increase between rank
categories or mice subsequently subjected to different treatments.
Although there were also no main effects of rank and treatment
in posttreatment groups, there was a suggestive interaction be-
tween the two; as might be expected from previous rank differ-
ences in IgG response during grouping (in which those of high-
rank showed a decline in IgG concentration (6) , the
posttreatment increase tended to be lower among those of high
rank following ATS treatment [F(1, 24)  3.28, 0.1  P 
0.05, Fig. 3] .
Effect of Treatment on Serum Hormone Concentrations
If mice modulate testosterone secretion in relation to current
immune status, we should expect a decline in serum concentra-
tion across the period of treatment in ATS-treated individuals.
Figure 4 shows that this was the case [F(1, 23)  3.84, 1-tailed
p  0.05], ATS-treated mice showing a reduction in serum con-
centration compared with a slight increase among NRS-treated
animals. Because there was no significant difference between
ATS- and NRS-treated mice in pretreatment testosterone con-
centration [F(1, 23)  0.008, NS], the greater decline in ATS-
treated animals resulted in significantly lower posttreatment
concentrations [F(1, 23)  3.94, 1-tailed p  0.05]. There was
no significant difference or interaction with rank and a significant
effect of current body weight only in the case of pretreatment
concentrations [F(1, 23) 4.51, p 0.05]. To relate the decline
in testosterone concentration over the period of treatment to our
measures of immunocompetence, we carried out a stepwise par-
tial regression analysis with thymus weight (as % body weight) ,
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FIG. 3. The interaction between rank category and treatment from
ANOVA of posttreatment total IgG concentration. Least-squares devia-
tion bars omitted from mean values for clarity. Treatments as in Fig. 1.
See text.
FIG. 4. Least-squares means from ANOVA of the change in testosterone
concentration across the 6-day period of treatment in ATS- and NRS-
treated mice. Treatments as in Fig. 1. See text.
haemagglutination titre, and the change in total IgG concentra-
tion and body weight over the same period as independent vari-
ables. No significant relationships emerged when treatments were
combined but, when analyzed separately, there was a strong pos-
itive relationship with thymus weight among ATS-treated mice
[ t(14)  2.43, p  0.005, Fig. 5] , showing that the smaller the
relative weight of the thymus gland, the greater the reduction in
testosterone concentration. When thymus weight had been taken
into account, however, there was a significant negative relation-
ship with the change in IgG concentration [ t(14)  03.50, p 
0.004].
No significant effects of treatment or rank category emerged
for corticosterone concentration and there were no significant
correlations between change in corticosterone and testosterone
concentrations over any phase of the experiment.
Analysis of changes in serum hormone concentration during
pre- and posttreatment periods of grouping accorded with results
from previous experiments with groups of male CFLP mice [e.g.,
(5)] , with the exception of posttreatment ATS groups. In all
cases except for posttreatment ATS mice, testosterone concen-
tration tended to decline over the period of grouping, and in all
cases corticosterone concentration tended to increase (Table 2) .
There were no significant differences in the degree of change
between treatments for either hormone.
Effect of Treatment on Body and Organ Weights
Prior to separation and treatment, there was no significant
difference in body weight between mice subsequently given dif-
ferent treatments; neither was there a difference between rank
categories. However, ANOVA of the change in body weight over
the period of isolation and treatment revealed a significant dif-
ference between ATS- and NRS-treated animals, with the former
showing an increase in weight compared to a decrease in NRS
controls [F(1, 24)  12.34, p  0.01]. As a result, immediate
posttreatment weight differed significantly between the 2 groups
[F(1, 24)  5.48, p  0.03]. However, after the second period
of grouping, body weight ( terminal) again showed no difference
between treatment groups. There were no significant main or in-
teraction effects of rank.
Two-way ANOVA of organ weights (as % body weight)
other than the thymus gland (see above) revealed a significant
treatment effect only in case of the spleen, which was signifi-
cantly larger in ATS-treated animals [F(1, 25)  14.27, p 
0.001].
Effect of Treatment on Behaviour
Previous work (3–6) has indicated a role of aggressiveness
in status-related immunodepression and reduced resistance to
disease among male CFLP mice. We, therefore, expected treat-
ment with ATS to result in a reduction in the amount of aggres-
sion initiated. Because there was no interaction between treat-
ment and rank category in immunocompetence measures (see
above), however, there was no reason to expect a differential
effect of treatment with respect to rank on aggression. Two-way
ANOVA of the difference in the total amount of aggression ini-
tiated before and after treatment (post- minus pretreatment num-
ber of occurrences, taking post- minus pretreatment change in
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FIG. 5. Component effect from partial regression analysis of the rela-
tionship between thymus weight (% terminal body weight) and the
change in testosterone concentration among ATS-treated mice over the
6-day period of treatment. Regression equation: y  031.81 /
139.41(th) 0 0.02(tigg), where th  relative thymus weight and tigg
 post- minus pretreatment change in total IgG concentration. No other
independent variable entered the equation. See text.
FIG. 6. Least-squares means from ANOVA of the post- minus pretreat-
ment change in the amount of aggressive behaviour initiated by ATS-
and NRS-treated mice. Treatments and bars as in Fig. 1.
body weight into account as a covariate, see above) confirmed a
treatment effect, with the number of initiations being reduced to
a greater extent after ATS treatment than after NRS treatment
[F(1, 23)  3.04, 1-tailed p  0.05, Fig. 6] . There was also a
significant difference between rank categories, with the decline
being much greater among those of high rank than among low
ranking animals [F(1, 23)  13.45, p  0.005], but no signif-
icant interaction between treatment and rank category. There was
no significant effect of change in body weight and no significant
pretreatment difference in aggressiveness between the 2 treat-
ment groups. Analysis of the degree of escalation in aggressive
encounters revealed a reduction in ATS mice compared with
NRS controls (mean{ SE change in ATS mice01.03{ 0.41;
in NRS mice  0.07 { 0.82), but the difference was not signif-
icant. Contrary to expectation, there was no corresponding in-
crease in social investigation, and no significant change in other
social behaviours (allogrooming, mounting) sometimes associ-
ated with aggression (20,24).
Compromising immune function might also be expected to
depress general activity if metabolic demand is likely further to
depress immunocompetence. In keeping with this, 2-way
ANOVA showed a significant effect of treatment on the differ-
ence in the number of times mice were recorded in general lo-
comotory activity (combined mobile, climb, dig in sawdust, in-
vestigate cage, in Table 1, [F(1, 24)  6.60, 1-tailed p  0.01]
and sleeping [F(1, 23)  5.53, 1-tailed p  0.03] before and
after treatment. Levels of locomotory activity were maintained
after treatment among NRS animals, but declined in ATS-treated
mice, and the converse was true for time spent sleeping (Fig.
7a,b) . Because ATS treatment resulted in a greater decline in
PCV [F(1, 24)  5.42, P  0.03], we controlled for potential
effects of erythrocyte loss on the tendency to sleep, by taking the
change in PCV into account as a covariate in the above analysis.
There were no significant covariate, main, or interaction effects
relating to rank category. There were also no significant pretreat-
ment differences in locomotory activity or sleeping between the
2 treatment groups. There were no significant changes in any
other behaviour category (Table 1) . Although both aggression
and locomotory activity decreased after ATS treatment, there was
no significant correlation between the two [r (28)  0.24, NS],
implying that the change in aggression was not simply a trivial
consequence of an overall reduction in activity.
Relationships Between Immunocompetence, Hormone
Concentration, and Behaviour
If the above effects of treatment on subsequent behaviour re-
flected modulation of behaviour in response to immunodepres-
sion, we should expect a positive association between the degree
of change in immunocompetence over the period of treatment
and the corresponding degree of change in aggression, and a
negative association with the change in sleeping. To test this, we
used stepwise partial regression analysis (combining treatments
and rank categories) with change in behaviour (post- minus pre-
treatment number of occurrences) as the dependent variable, and
thymus weight, haemagglutination titre, and (post- minus pre-
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FIG. 7. Least-squares means from ANOVA of the post- minus pretreatment change in the amount of (a) locomotory behaviour and (b) sleep among
ATS- and NRS-treated mice. Treatments and bars as in Fig. 1.
treatment) changes in body weight and total IgG and testosterone
concentrations as independent variables. Change in corticoster-
one concentration was not included because no treatment effect
emerged for corticosterone (see above) and previous studies of
CFLP and other strains of mice [e.g., (9)] suggest that changes
in corticosterone concentration in the context of social interac-
tions are consequent on, rather than preludes to, individual dif-
ferences in aggression [but see (19) for associations in rats] .
The results showed that the change in aggression was positively
related to the change in total IgG [ t(26)  3.33, 1-tailed p 
0.002, Fig. 8] , but not to thymus weight or haemagglutination
titre. Animals showing the greatest reduction in IgG over the
period of treatment, thus, showed the greatest subsequent reduc-
tion in aggression. The relationship was significant for both ATS-
and NRS-treated mice when analyzed separately [ATS, t(14) 
3.06, 1-tailed p  0.01; NRS, t(10)  3.29, 1-tailed p  0.01],
implying that the treatment effect on aggression above was due
to the greater reduction in immunocompetence among ATS-
treated mice, rather than to some other effect of ATS treatment.
Despite the absence of a significant difference between treat-
ments for social investigation (see above), partial regression
analysis of the change in investigatory activity after treatment in
ATS mice nevertheless revealed a significant positive relation-
ship with thymus weight [ t(14)  3.58, 1-tailed p  0.01, Fig.
9] . Investigation thus increased to a greater extent in those ATS-
treated animals maintaining a greater relative thymus weight.
There were no significant relationships among NRS mice or
when treatments were combined.
Likewise, regression analysis of NRS and combined treat-
ments failed to yield any significant relationships for locomotory
activity or sleep, but strongly significant associations with thy-
mus weight emerged among ATS-treated animals (for locomo-
tory activity, t(14)  4.77, 1-tailed p  0.0001, Fig. 10a; for
sleep, t(14)03.78, 1-tailed p 0.002, Fig. 10b]. ATS-treated
mice, thus, reduced the amount of locomotory activity but main-
tained the amount of sleep after treatment in proportion to the
reduction in relative thymus weight. No other significant rela-
tionships emerged for sleep.
If aggression was damped in response to a preceding decline
in immunocompetence, was there any evidence that greater levels
of posttreatment aggression, either initiated or received (6) cor-
respondingly damped the apparent posttreatment recovery (at
least as measurable by the change in total IgG)? Stepwise partial
regression analysis with the change in IgG across the posttreat-
ment period of grouping as the dependent variable, and posttreat-
ment aggression, social investigation, sleep, and change in body
weight and testosterone concentration as independent variables,
failed to reveal any effect of aggression. However, posttreatment
sleep showed a significant negative association with posttreat-
ment change in IgG [ t(26)  02.11, p  0.05]. When treat-
ments were analyzed separately, the trend remained only among
ATS-treated mice [ t(14)  02.91, p 0.02) which, in a further
analysis, also showed a significant negative relationship between
posttreatment sleep and thymus weight [ t(14)  03.29, p 
0.006]. No significant relationships were found for social inves-
tigation.
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FIG. 8. Component effect from partial regression analysis of the rela-
tionship between the change in total IgG concentration over the 6-day
period of treatment and the post- minus pretreatment change in the
amount of aggression initiated (treatments combined). Regression equa-
tion: y  00.10 / 0.003(tigg). Abbreviations as in Fig. 5. No other
independent variables entered the equation. See text.
FIG. 9. Component effect from partial regression analysis of the rela-
tionship between thymus weight (% terminal body weight) and the post-
minus pretreatment change in the amount of social investigation initiated
by ATS-treated mice. Regression equation: y  043.24 / 453.81(th) .
Abbreviations as in Fig. 5. No other independent variables entered the
equation. See text.
DISCUSSION
Our expectation that induced immunodepression would result
in downregulation of potentially immunodepressive hormones
and aggressive behaviour was borne out by the results. However,
apart from an interaction in posttreatment recovery of IgG con-
centration, there was little evidence for a difference between rank
categories in response to treatment.
The absence of a detectable antibody response to the injection
of SRBC confirmed that ATS-treated mice were severely immu-
nodepressed, and the reduction in total IgG concentration following
treatment indicated that pre-existing immune responses were also
temporarily affected. Total IgG concentration declined over the pe-
riod during which mice were separated and treated with ATS, but
then increased as the immunodepressive effect waned following the
cessation of treatment and mice presumably responded to the foreign
proteins in the rabbit serum. Treatment with ATS during the exper-
iment was associated with a reduction in relative thymus weight and
an increase in spleen weight, the latter an expected consequence
(12) of increased haemopoiesis following partial reduction in eryth-
rocytes as a consequence of some cross-reactivity of ATS. The PCV
fell marginally in ATS-treated mice, but values remained well within
the limit tolerated by mice.
The change in IgG was reflected by a simultaneous change in
serum testosterone concentration. However, when relationships
were partialled out, the decline in testosterone among ATS-
treated mice correlated with a reduction in relative thymus
weight, rather than IgG concentration, supporting the idea of
some thymus-mediated regulation of hormone secretion (15).
That testosterone, but not corticosterone, tracked changes in im-
munocompetence measures is consistent with previously re-
ported differences in the apparent modulation of the two hor-
mones in relation to current immune status (5,32).
Our interpretation of the association between testosterone and
immunocompetence in terms of downregulating a potential im-
munodepressant when immune function is impaired is supported
by the observed behavioural changes. ATS-treated mice showed
a reduction in the amount of aggression initiated and general
activity relative to pretreatment levels when groups were recon-
stituted after treatment, and levels of activity, particularly ag-
gression, were expected to be high (3,29), but maintained pre-
treatment levels of sleep. The fact that the reduction in aggression
correlated with that in total IgG concentration across the period
of treatment, in both ATS and naive serum control mice, strength-
ens the conclusion that the treatment effect was the result of
increased immunodepression among ATS mice. The relation-
ships between immunocompetence and time spent in social in-
vestigation and sleep were confined to ATS-treated animals and
related to the reduction in relative thymus weight, rather than
IgG concentration. As in the case of aggression, however, there
was no association with testosterone concentration. The lack of
any independent association between testosterone concentration
and behaviour concurs with previous findings, in which evidence
for relationships between testosterone levels and aggression
among male CFLP mice is weak [(5,32) see also (10), but see
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FIG. 10. Component effect from partial regression analysis of the relationship between thymus weight (% terminal body weight) and post- minus
pretreatment change in the amount of (a) locomotor behaviour and (b) sleep among ATS-treated mice. Regression equations: (a) y  019.59 /
137.15(th) , (b) y  32.05 0 335.53(th) , respectively. Abbreviations as in Fig. 5. No other independent variables entered the equations. See text.
(4)] , and suggests that hormonal and behavioural changes are
independent responses to immunodepression.
Surprisingly, the amount of aggression initiated or received
did not affect the posttreatment rise in IgG or any of our other
measures of immunocompetence. However, the smaller increase
in IgG among ATS-treated high-rank animals suggested an in-
direct association between aggressiveness and recovery of anti-
body response. Although posttreatment aggression had little im-
pact on changes in immunocompetence measures, there was an,
at first sight, counterintuitive negative relationship between time
spent sleeping and both thymus weight and rise in IgG (implying
that animals that slept more ended up with smaller thymus glands
and showed less recovery in IgG concentration) . Because the
increase in sleep after treatment was a function of reduced thy-
mus weight, however, a plausible explanation for the posttreat-
ment relationship might be that more severely immunocomprom-
ised individuals both slept more and showed a weaker recovery
of thymus cells and IgG levels, but that behaviour and immu-
nocompetence measures were not causally related.
Overall, the results of the experiment strongly support the idea
that aspects of behaviour and physiology affecting immunocom-
petence may be modulated in relation to current immune status.
They complement previous results relating to spontaneous
changes in hormone concentrations, behaviour, and immune
function in male CFLP mice in suggesting an important role of
immune function in behavioural and physiological decision-
making.
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